143 related articles for article (PubMed ID: 33741765)
1. Ovarian Clear Cell Tumors Associated With Seromucinous Borderline Tumor: A Case Series.
Vroobel KM; McCluggage WG
Int J Gynecol Pathol; 2022 Jan; 41(1):76-81. PubMed ID: 33741765
[TBL] [Abstract][Full Text] [Related]
2. Clear cell carcinoma arising in a seromucinous borderline tumor with co-existing endometriosis- Case report of a rare association.
Karnik N; Rekhi B
Indian J Pathol Microbiol; 2020; 63(4):676-678. PubMed ID: 33154340
[No Abstract] [Full Text] [Related]
3. Seromucinous ovarian tumor A comparison with the rest of ovarian epithelial tumors.
Karpathiou G; Chauleur C; Corsini T; Venet M; Habougit C; Honeyman F; Forest F; Peoc'h M
Ann Diagn Pathol; 2017 Apr; 27():28-33. PubMed ID: 28325358
[TBL] [Abstract][Full Text] [Related]
4. [Expression of ARID1A in ovarian seromucinous neoplasms and its clinicopathological significance].
Ding XH; Tian X; Wang LQ; Wang Y; Liu AJ
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):588-593. PubMed ID: 32486536
[No Abstract] [Full Text] [Related]
5. Borderline clear cell adenofibroma of the ovary associated with ovarian endometriosis: a case report.
Vasilakaki T; Skafida E; Arkoumani E; Grammatoglou X; Firfiris N; Manoloudaki K
Eur J Gynaecol Oncol; 2012; 33(2):230-2. PubMed ID: 22611972
[TBL] [Abstract][Full Text] [Related]
6. Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A.
Wu CH; Mao TL; Vang R; Ayhan A; Wang TL; Kurman RJ; Shih IeM
Int J Gynecol Pathol; 2012 Jul; 31(4):297-303. PubMed ID: 22653341
[TBL] [Abstract][Full Text] [Related]
7. A pregnant woman with clear cell adenocarcinoma of the ovary arising from endometriosis and with benign and borderline adenofibroma of the clear cell and endometrioid types.
Sugiyama T; Nishida T; Kataoka A; Okura N; Iwanaga S; Yakushiji M
Eur J Obstet Gynecol Reprod Biol; 1997 Mar; 72(1):47-50. PubMed ID: 9076421
[TBL] [Abstract][Full Text] [Related]
8. Endometriosis-associated epithelial ovarian cancer is a more complicated disease than we suspected before.
Yang ST; Chang WH; Lee NR; Lai WA; Shen SH; Lee WL; Wang PH
Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1112-1115. PubMed ID: 34794748
[TBL] [Abstract][Full Text] [Related]
9. Cytological Appearances of Ovarian Seromucinous Borderline Tumor in Ascites: Presentation of 2 Cases.
Kai K; Hashiguchi M; Kurihara M; Tanaka Y; Kitamura S; Nakamura M; Shichijo C; Yamamoto-Rikitake M; Okuma R; Hikari T; Okuma E; Uchiyama M; Aoki S; Nakao Y; Yokoyama M; Aishima S
Acta Cytol; 2021; 65(5):440-447. PubMed ID: 34284376
[TBL] [Abstract][Full Text] [Related]
10. PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis.
Yun BS; Won S; Kim JH; Lee N; Kim M; Kim MK; Kim ML; Jung YW; Kim JY; Seong SJ; Shin E
J Ovarian Res; 2022 Apr; 15(1):41. PubMed ID: 35387670
[TBL] [Abstract][Full Text] [Related]
11. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm.
Taylor J; McCluggage WG
Am J Surg Pathol; 2015 Jul; 39(7):983-92. PubMed ID: 25723110
[TBL] [Abstract][Full Text] [Related]
12. Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations.
Yamamoto S; Tsuda H; Takano M; Tamai S; Matsubara O
Mod Pathol; 2012 Apr; 25(4):615-24. PubMed ID: 22157930
[TBL] [Abstract][Full Text] [Related]
13. Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy.
Okumura T; Muronosono E; Tsubuku M; Terao Y; Takeda S; Maruyama M
J Ovarian Res; 2018 Sep; 11(1):77. PubMed ID: 30176911
[TBL] [Abstract][Full Text] [Related]
14. Ovarian seromucinous cystadenomas and adenofibromas: first report of a case series.
Ben-Mussa A; McCluggage WG
Histopathology; 2021 Feb; 78(3):445-452. PubMed ID: 32810322
[TBL] [Abstract][Full Text] [Related]
15. Identical twins with ovarian endometriosis and mucinous borderline tumor: an unusual association.
Ko ML; Pan HS
Fertil Steril; 2008 Oct; 90(4):1200.e7-9. PubMed ID: 18258232
[TBL] [Abstract][Full Text] [Related]
16. ARID1A expression in ovarian clear cell carcinoma with an adenofibromatous component.
Nishikimi K; Kiyokawa T; Tate S; Iwamoto M; Shozu M
Histopathology; 2015 Dec; 67(6):866-71. PubMed ID: 25913291
[TBL] [Abstract][Full Text] [Related]
17. Müllerian Mucinous Cystadenomas of the Ovary: A Report of 25 Cases of an Unheralded Benign Ovarian Neoplasm Often Associated With Endometriosis and a Brief Consideration of Neoplasms Arising From the Latter.
Watkins JC; Young RH
Int J Gynecol Pathol; 2022 Jan; 41(1):68-75. PubMed ID: 33577227
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic Features and the Loss of ARID1A Expression in Ovarian Seromucinous Borderline Tumors and Seromucinous Carcinomas.
Ok Atılgan A; Özen Ö; Haberal Reyhan AN; Ayhan A
Int J Surg Pathol; 2023 Jun; 31(4):398-408. PubMed ID: 36452965
[TBL] [Abstract][Full Text] [Related]
19. A Case of Stage 4B Seromucinous Ovarian Borderline Tumor With Endometriosis and Review of the Literature.
Newton CL; Brockbank E; Singh N; Faruqi A
Int J Gynecol Pathol; 2017 Mar; 36(2):195-199. PubMed ID: 27362901
[TBL] [Abstract][Full Text] [Related]
20. ARID1A mutations in endometriosis-associated ovarian carcinomas.
Wiegand KC; Shah SP; Al-Agha OM; Zhao Y; Tse K; Zeng T; Senz J; McConechy MK; Anglesio MS; Kalloger SE; Yang W; Heravi-Moussavi A; Giuliany R; Chow C; Fee J; Zayed A; Prentice L; Melnyk N; Turashvili G; Delaney AD; Madore J; Yip S; McPherson AW; Ha G; Bell L; Fereday S; Tam A; Galletta L; Tonin PN; Provencher D; Miller D; Jones SJ; Moore RA; Morin GB; Oloumi A; Boyd N; Aparicio SA; Shih IeM; Mes-Masson AM; Bowtell DD; Hirst M; Gilks B; Marra MA; Huntsman DG
N Engl J Med; 2010 Oct; 363(16):1532-43. PubMed ID: 20942669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
